ID: ALA4216987

Max Phase: Preclinical

Molecular Formula: C27H38N4O2

Molecular Weight: 450.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(/C=N\N=C1/C[C@@H]2[C@@H](CC)CN(C)[C@@H](Cc3c1[nH]c1ccccc31)[C@@H]2C(=O)OC)CC

Standard InChI:  InChI=1S/C27H38N4O2/c1-6-17(7-2)15-28-30-23-13-20-18(8-3)16-31(4)24(25(20)27(32)33-5)14-21-19-11-9-10-12-22(19)29-26(21)23/h9-12,15,17-18,20,24-25,29H,6-8,13-14,16H2,1-5H3/b28-15-,30-23+/t18-,20+,24-,25+/m0/s1

Standard InChI Key:  UPYDXCKCZQPTQF-ATNCZHNNSA-N

Associated Targets(Human)

Multidrug resistance-associated protein 1 2587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ATP-binding cassette sub-family G member 2 4927 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BHK-21 725 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.63Molecular Weight (Monoisotopic): 450.2995AlogP: 5.07#Rotatable Bonds: 6
Polar Surface Area: 70.05Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.57CX Basic pKa: 8.46CX LogP: 4.48CX LogD: 3.38
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: 0.90

References

1. Paterna A, Khonkarn R, Mulhovo S, Moreno A, Madeira Girio P, Baubichon-Cortay H, Falson P, Ferreira MU..  (2018)  Monoterpene indole alkaloid azine derivatives as MDR reversal agents.,  26  (2): [PMID:29233614] [10.1016/j.bmc.2017.11.052]

Source